TSSeasider
Well-known member
AstraZeneca vaccine safe and effective in new trial data
AstraZeneca's COVID-19 vaccine developed with Oxford University was 79% effective in preventing symptomatic illness in a large trial in Chile, Peru and the United States, the company said on Monday, paving the way for it to apply for U.S. approval.
www.reuters.com
Good news, very good news.